Paper41908232
Irreversible electroporation for localized prostate cancer: risk-stratified oncologic outcomes and functional preservation.
Xia ZY and 6 others. Prostate Int, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Irreversible electroporation for localized prostate cancer: risk-stratified oncologic outcomes and functional preservation. Papers, record 41908232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41908232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Irreversible electroporation for localized prostate cancer: risk-stratified oncologic outcomes and functional preservation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27809908 | Cognitive biases associated with medical decisions: a systematic review. | BMC Med Inform Decis Mak | 2016 | https://conductscience.org/library/papers/27809908 | PubMed |
| 2 | 36910902 | Irreversible electroporation for prostate cancer using PSMA PET-CT. | Prostate Int | 2023 | https://conductscience.org/library/papers/36910902 | PubMed |
| 3 | 35125113 | Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. | BMC Med | 2022 | https://conductscience.org/library/papers/35125113 | PubMed |
| 4 | 36509074 | NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023. | J Natl Compr Canc Netw | 2022 | https://conductscience.org/library/papers/36509074 | PubMed |
| 5 | 30342843 | Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. | Eur Urol | 2019 | https://conductscience.org/library/papers/30342843 | PubMed |
| 6 | 37748776 | Artificial intelligence-assisted ultrasound-guided focused ultrasound therapy: a feasibility study. | Int J Hyperthermia | 2023 | https://conductscience.org/library/papers/37748776 | PubMed |
| 7 | 37544833 | A multi-institutional study of 1,111 men with 4K score, multiparametric magnetic resonance imaging, and prostate biopsy. | Urol Oncol | 2023 | https://conductscience.org/library/papers/37544833 | PubMed |
| 8 | 39589586 | Advances in irreversible electroporation for prostate cancer. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39589586 | PubMed |
| 9 | 39668103 | Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update. | Eur Urol | 2025 | https://conductscience.org/library/papers/39668103 | PubMed |
| 10 | 34162858 | Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells. | Nat Commun | 2021 | https://conductscience.org/library/papers/34162858 | PubMed |
| 11 | 37409092 | Combination of multiparametric magnetic resonance imaging and transperineal template-guided mapping prostate biopsy to determine potential candidates for focal therapy. | Prostate Int | 2023 | https://conductscience.org/library/papers/37409092 | PubMed |
| 12 | 27595377 | New and Established Technology in Focal Ablation of the Prostate: A Systematic Review. | Eur Urol | 2017 | https://conductscience.org/library/papers/27595377 | PubMed |
| 13 | 39505512 | Prostate cancer theragnostics biomarkers: An update. | Investig Clin Urol | 2024 | https://conductscience.org/library/papers/39505512 | PubMed |
| 14 | 38614820 | EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. | Eur Urol | 2024 | https://conductscience.org/library/papers/38614820 | PubMed |
| 15 | 24656178 | Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. | J Vasc Interv Radiol | 2014 | https://conductscience.org/library/papers/24656178 | PubMed |
| 16 | 40053175 | A preliminary follow-up study on irreversible electroporation therapy in older patients with prostate cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40053175 | PubMed |
| 17 | 32208094 | High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy. | Radiology | 2020 | https://conductscience.org/library/papers/32208094 | PubMed |
| 18 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 19 | 40221374 | Long-term Oncological Outcomes of Partial Gland Cryoablation of Localized Prostate Cancer with Median Follow-up of 7 Years: A Single-institution Experience. | Eur Urol Focus | 2025 | https://conductscience.org/library/papers/40221374 | PubMed |
| 20 | 37858454 | Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer. | Eur Urol | 2024 | https://conductscience.org/library/papers/37858454 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42382550 | Irreversible electroporation in focal therapy for prostate cancer: current status and future directions. | Prostate Int | 2026 | https://conductscience.org/library/papers/42382550 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NPEPPS | 9520 | PubTator's text mining | https://conductscience.org/library/genes/9520 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41908232
GET https://conductscience.org/api/papers/v1/41908232/references?page=2